SecSonar.com

Daxor Corporation (DXR)

Daxor Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Daxor Corporation (DXR) is a Medical - Instruments & Supplies company based in US with a market capitalization of $49.3M. Revenue declined 76.4% year-over-year and free cash flow was negative at -$604.4K. This page tracks DXR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 37 employees · IPO Jul 25, 1983

Valuation

Valuation & price

$10.75 · as of May 17, 2026 · -27.1% vs 52w high

5.8

P/E ratio

Latest-FY diluted EPS

1.07

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$14.44$11.65$8.87Jul 25Dec 25Jul 26Jul 7, 25$9.86Jul 9, 25$9.50Jul 11, 25$9.29Jul 15, 25$9.50Jul 17, 25$9.35Jul 21, 25$9.18Jul 23, 25$9.63Jul 25, 25$10.14Jul 29, 25$10.26Jul 31, 25$9.92Aug 4, 25$9.66Aug 6, 25$10.00Aug 11, 25$10.09Aug 13, 25$11.03Aug 15, 25$10.60Aug 19, 25$10.41Aug 21, 25$10.84Aug 25, 25$10.85Aug 27, 25$11.34Aug 29, 25$11.00Sep 3, 25$10.63Sep 5, 25$11.06Sep 9, 25$11.40Sep 11, 25$11.11Sep 16, 25$11.43Sep 18, 25$11.40Sep 22, 25$11.76Sep 24, 25$11.74Sep 26, 25$12.05Sep 30, 25$13.77Oct 2, 25$14.00Oct 6, 25$13.81Oct 8, 25$13.08Oct 10, 25$12.61Oct 14, 25$12.83Oct 16, 25$13.00Oct 21, 25$13.54Oct 23, 25$13.60Oct 27, 25$11.45Oct 29, 25$13.43Oct 31, 25$13.33Nov 4, 25$13.50Nov 6, 25$13.13Nov 10, 25$12.80Nov 12, 25$12.80Nov 14, 25$13.00Nov 18, 25$12.94Nov 20, 25$13.00Nov 25, 25$13.00Nov 28, 25$13.30Dec 2, 25$13.10Dec 4, 25$12.85Dec 8, 25$12.85Dec 10, 25$12.50Dec 12, 25$12.25Dec 16, 25$12.31Dec 18, 25$12.38Dec 22, 25$12.62Dec 24, 25$13.82Dec 29, 25$14.44Jan 2, 26$14.36Jan 6, 26$13.68Jan 8, 26$13.80Jan 12, 26$14.24Jan 14, 26$13.48Jan 16, 26$13.70Jan 21, 26$13.71Jan 23, 26$12.59Jan 27, 26$12.72Jan 29, 26$12.46Feb 2, 26$12.21Feb 4, 26$12.60Feb 9, 26$12.25Feb 11, 26$12.59Feb 13, 26$12.40Feb 18, 26$12.20Feb 20, 26$12.21Feb 24, 26$12.00Feb 26, 26$11.95Mar 2, 26$11.38Mar 4, 26$11.64Mar 6, 26$11.38Mar 10, 26$11.48Mar 12, 26$11.50Mar 17, 26$11.39Mar 19, 26$11.12Mar 23, 26$10.51Mar 25, 26$10.39Mar 27, 26$10.14Mar 31, 26$9.67Apr 2, 26$9.70Apr 7, 26$8.87Apr 9, 26$9.40Apr 13, 26$9.43Apr 15, 26$9.43Apr 17, 26$10.01Apr 22, 26$10.10Apr 24, 26$10.25Apr 28, 26$11.54Apr 30, 26$10.80May 4, 26$10.12May 6, 26$10.14May 8, 26$9.95May 12, 26$10.50May 14, 26$10.50May 18, 26$10.95May 20, 26$11.35May 22, 26$10.82May 28, 26$9.88Jun 1, 26$10.06Jun 3, 26$10.73Jun 5, 26$10.60Jun 9, 26$10.00Jun 11, 26$9.76Jun 15, 26$9.67Jun 17, 26$9.40Jun 22, 26$9.50Jun 24, 26$10.50Jun 26, 26$10.02Jul 2, 26$10.38
$8.8752-week range$14.75
Loading valuation history…

Fundamentals

Key fundamentals

$49.3M

Market cap

-76.4%

Revenue growth (YoY)

37.5%

Gross margin

-$604.4K

Free cash flow (USD)

$112K

Net debt

3.0%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.8MFY 2017$-1.0MFY 2018$-918.4KFY 2019$-115.0KFY 2020$-2.8MFY 2021$-2.6MFY 2022$-353.4KFY 2023$34.6MFY 2024$2.1MFY 2025$503.4K
$1.8M$503.4K

Free cash flow by year

2016 → 2025

FY 2016$1.6MFY 2017$-1.2MFY 2018$-1.3MFY 2019$3.1MFY 2020$-2.4MFY 2021$-2.8MFY 2022$-769.3KFY 2023$-3.7MFY 2024$25.7KFY 2025$-604.4K
$1.6M-$604.4K

Gross margin by year

2021 → 2025

FY 2021138.3%FY 2022407.6%FY 202399.5%FY 2024100.0%FY 202537.5%
138.3%37.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

1

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: —

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 24, 2026Filing
  • Insider buyInsider Buy $9KFeldschuh Michael Richard · Director, Chief Executive Officer · $9.1KApr 10, 2026Filing
  • Insider buyInsider Buy $10KMichel Robert J · Chief Financial Officer · $9.9KMar 31, 2026Filing

Questions

Frequently asked questions

What is Daxor Corporation's market cap?

Daxor Corporation (DXR) has a market capitalization of $49.3M.

What is DXR's P/E ratio?

DXR trades at a price-to-earnings ratio of 5.8, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is DXR's price-to-book (P/B) ratio?

DXR trades at 1.07 times book value per share.

Are insiders buying DXR stock?

Yes — SEC Form 4 filings show 1 open-market insider buy and 0 sells at Daxor Corporation in the last 90 days.

Same arena

Related companies in Medical - Instruments & Supplies

POCI

Precision Optics Corporation, Inc.

$42.4M

NEPH

Nephros, Inc.

$40.2M

ZTEK

Zentek Ltd.

$63.2M

MLSS

Milestone Scientific Inc.

$33.7M

HBIO

Harvard Bioscience, Inc.

$26.7M

STSS

Sharps Technology, Inc.

$77.9M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.